EP0177583A4 - Vaccin ou procede de diagnostic utilisant un peptide et polypeptide indique pour cette utilisation. - Google Patents

Vaccin ou procede de diagnostic utilisant un peptide et polypeptide indique pour cette utilisation.

Info

Publication number
EP0177583A4
EP0177583A4 EP19850901876 EP85901876A EP0177583A4 EP 0177583 A4 EP0177583 A4 EP 0177583A4 EP 19850901876 EP19850901876 EP 19850901876 EP 85901876 A EP85901876 A EP 85901876A EP 0177583 A4 EP0177583 A4 EP 0177583A4
Authority
EP
European Patent Office
Prior art keywords
diagnostic
peptide vaccine
polypeptide useful
useful therefor
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19850901876
Other languages
German (de)
English (en)
Other versions
EP0177583A1 (fr
Inventor
Magdalene Y H So
Carolyn D Deal
Per O Hagblom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of EP0177583A1 publication Critical patent/EP0177583A1/fr
Publication of EP0177583A4 publication Critical patent/EP0177583A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19850901876 1984-04-06 1985-04-04 Vaccin ou procede de diagnostic utilisant un peptide et polypeptide indique pour cette utilisation. Withdrawn EP0177583A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59743484A 1984-04-06 1984-04-06
US597434 1984-04-06

Publications (2)

Publication Number Publication Date
EP0177583A1 EP0177583A1 (fr) 1986-04-16
EP0177583A4 true EP0177583A4 (fr) 1988-06-08

Family

ID=24391484

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19850901876 Withdrawn EP0177583A4 (fr) 1984-04-06 1985-04-04 Vaccin ou procede de diagnostic utilisant un peptide et polypeptide indique pour cette utilisation.

Country Status (9)

Country Link
EP (1) EP0177583A4 (fr)
JP (1) JPS61501777A (fr)
AU (1) AU582358B2 (fr)
FI (1) FI81452C (fr)
IL (1) IL74829A (fr)
NO (1) NO854903L (fr)
NZ (1) NZ211715A (fr)
WO (1) WO1985004654A1 (fr)
ZA (1) ZA852629B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736017A (en) * 1984-04-30 1988-04-05 The Board Of Trustees Of The Leland Stanford Junior University Chemically defined vaccine against urinary infections
US4584195A (en) * 1984-06-21 1986-04-22 The Board Of Trustees Of The Leland Stanford Junior University Broad spectrum vaccine against gonorrhea
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
SE8601940D0 (sv) * 1986-04-25 1986-04-25 Kabigen Ab Preparation of fused proteins, antibodies and processes therefor
AU5403594A (en) * 1992-10-07 1994-04-26 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Pilin variants and uses thereof
WO1999055875A2 (fr) * 1998-04-29 1999-11-04 American Cyanamid Company VACCINS CONTENANT DE LA PILINE DE RECOMBINAISON UTILISES CONTRE LES MALADIES PROVOQUEES PAR NEISSERIA GONORRHOEAE OU $i(NEISSERIA MENINGITIDIS)
US7189405B1 (en) 1999-10-29 2007-03-13 Rice Peter A Peptide mimics of conserved gonococcal epitopes and methods and compositions using them

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186182A (en) * 1975-02-28 1980-01-29 Research Corporation Serological test for Neisseria gonorrhoeae antibodies
US4461838A (en) * 1975-04-25 1984-07-24 Bactex, Inc. Gonococcal Pili processes for the preparation thereof and the use thereof for the detection of and prevention of infections caused by Neisseria gonorrhoeae
US4188371A (en) * 1977-09-28 1980-02-12 Corning Glass Works Immunological detection of Neisseria bacteria via labelled antibodies
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4351761A (en) * 1978-05-15 1982-09-28 Research Corporation Purified antigen to test for Neisseria gonorrhoeae antibodies
US4330623A (en) * 1980-02-19 1982-05-18 Merck & Co., Inc. Process for solubilization of gonococcal antigen
US4386066A (en) * 1981-08-20 1983-05-31 Merck & Co., Inc. Immunogenic complex from N. gonorrhoeae
US4497900A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 103, 1985, page 493, abstract no. 69459u, Columbus, Ohio, US; D.S. STEPHENS et al.: "Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili", & J. EXP. MED. 1985, 16(6), 1539-53 *
PROC. NATL. ACAD. SCI. USA, vol. 82, February 1985, pages 915-919; J.B. ROTHBARD et al.: "Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion" *
See also references of WO8504654A1 *

Also Published As

Publication number Publication date
IL74829A (en) 1989-02-28
FI81452C (fi) 1990-10-10
FI81452B (fi) 1990-06-29
NO854903L (no) 1986-02-04
AU4159085A (en) 1985-11-01
JPS61501777A (ja) 1986-08-21
NZ211715A (en) 1989-01-27
FI854839A (fi) 1985-12-05
EP0177583A1 (fr) 1986-04-16
ZA852629B (en) 1985-11-27
FI854839A0 (fi) 1985-12-05
WO1985004654A1 (fr) 1985-10-24
IL74829A0 (en) 1985-07-31
AU582358B2 (en) 1989-03-23

Similar Documents

Publication Publication Date Title
DE68912268D1 (en) Elastomere polypeptide als vaskulare prothesematerialien.
OA07983A (en) A novel human physiologically active polypeptide.
EP0232407A4 (fr) Micro-emulsions pharmaceutiques.
IL81839A0 (en) Polypeptide,dna and its use
DE3789413T2 (de) Lymphokin-ähnliche Peptide.
IL90209A0 (en) Dna coding for a hiv-1 protein,the protein produced and its use
NO892294D0 (no) Polypeptidforbindelser.
DE3581337D1 (en) Peptide.
ZA878336B (en) Peptides
EP0585216A4 (fr) Peptides contre la mononucleose infectieuse.
EP0177583A4 (fr) Vaccin ou procede de diagnostic utilisant un peptide et polypeptide indique pour cette utilisation.
EP0309566A4 (fr) Polypeptides se rapportant au stlv-iii, systemes de diagnostic et methodes d'analyse.
EP0148942A4 (fr) Peptides de potentiation d'insuline.
FI851488A0 (fi) Peptider.
EP0253873A4 (fr) Polypeptides d'activation de lymphocytes.
EP0191854A4 (fr) Peptides anti-viraux.
EP0189485A4 (fr) Hexapeptide.
GB2171701B (en) 8-oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxylic acids
DE3686799D1 (en) Fuer dipterenlarven toxische polypeptide.
EP0261239A4 (fr) Peptide stimulant la secretion de l'hormone foliculo-stimulante (fsh).
EP0308424A4 (fr) Nouvelle proteine designee neuroleukine.
ZA878945B (en) Peptides
ZA873796B (en) Peptides
GB8715737D0 (en) Polypeptide
GB8723507D0 (en) Polypeptide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19860327

RIN1 Information on inventor provided before grant (corrected)

Inventor name: HAGBLOM, PER, O.

Inventor name: DEAL, CAROLYN, D.

Inventor name: SO, MAGDALENE, Y., H.

A4 Supplementary search report drawn up and despatched

Effective date: 19880608

17Q First examination report despatched

Effective date: 19901105

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19920504

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DEAL, CAROLYN, D.

Inventor name: HAGBLOM, PER, O.

Inventor name: SO, MAGDALENE, Y., H.